表紙
市場調查報告書

全球藥物洗脫支架市場

Global Drug-Eluting Stents Market

出版商 BCC Research 商品編碼 969286
出版日期 內容資訊 英文 127 Pages
訂單完成後即時交付
價格
全球藥物洗脫支架市場 Global Drug-Eluting Stents Market
出版日期: 2020年11月04日內容資訊: 英文 127 Pages
簡介

全球藥物洗脫支架市場預計將以6.8%的複合年增長率增長,從2019年的67億美元增長到2024年的93億美元。

本報告分析了全球藥物洗脫支架市場,並概述了產品和技術,市場的基本結構,主要的市場推廣/限制因素以及市場規模/增長率/市場份額趨勢(過去)。 2年/未來5年),按地區/產品/用途/最終用戶劃分的詳細趨勢,法規制定/技術發展的動態,主要公司的概況,新冠狀病毒感染的影響(Covid-19)等等。將被收集並交付。

目錄

第1章簡介

第2章摘要要點

第3章醫療器械法規

  • 醫療設備的定義和分類
  • 世界各地的法規(美國/歐洲/日本)

第4章藥物洗脫支架:管道分析

  • 概述

第5章藥物洗脫支架:市場背景

  • 簡介
  • 市場歷史
  • 塗料和聚合物
  • DES中使用的藥物
  • 心血管疾病(CVD)
  • CVD的一般類型
  • CVD症狀
  • CVD危險因素
  • CVD處理方法

第6章藥物洗脫支架:市場動態

  • 市場動態
  • 市場促進因素
  • 市場約束因素

第7章感染傳播的新冠狀病毒感染(COVID-19)的影響

  • 簡介
  • 爆發
  • COVID-19的症狀
  • COVID-19的進展
  • 潛伏期
  • 流行病學
  • 世界範圍內確診的COVID-19病例和死亡人數
  • 各種組織與政府之間的合作
  • 疾病流行
  • 現狀和對醫療IT公司的影響(MedTech)
  • 備用手術(選擇性/非重要程序)
  • 製造業轉移
  • 延遲監管,臨床試驗,產品上市
  • 供應鏈中斷
  • 醫療旅遊

第8章按產品分類的市場

  • 全球藥物洗脫支架市場:按產品
  • 聚合物基藥物洗脫支架
    • 市場規模和預測
    • 市場分析
  • 無聚合物洗脫藥物支架

第9章按應用細分市場

  • 全球藥物洗脫支架市場:按應用
  • 冠狀動脈疾病(CAD)
  • 周圍動脈疾病(PAD)

第10章按最終用戶劃分的細分市場

  • 全球藥物洗脫支架市場:按最終用戶劃分
  • 醫院
  • 門診手術中心
  • 專科中心診所

第11章按地區劃分市場

  • 全球藥物洗脫支架市場:按地區
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 其他亞太國家
  • 拉丁美洲
  • 中東/非洲

第12章競爭情況

  • 全球公司份額分析
  • 企業合併/收購(併購)
  • 協議,業務合作/合作,產品發佈

第13章公司簡介

  • ABBOTT
  • ALVIMEDICA
  • B. BRAUN MELSUNGEN AG
  • BIOSENSORS INTERNATIONAL
  • BIOTRONIK SE & CO. KG
  • BOSTON SCIENTIFIC CORP.
  • COOK MEDICAL INC.
  • LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.
  • MEDTRONIC PLC
  • TERUMO CORP.

第14章附錄:首字母縮寫詞列表

目錄
Product Code: MDS026A

Highlights:

The global market for drug-eluting stents should grow from $6.7 billion in 2019 to $9.3 billion by 2024 at a compound annual growth rate (CAGR) of 6.8% during the period of 2019-2024.

The global market for polymer-based drug-eluting stents should grow from $4.1 billion in 2019 to $5.4 billion by 2024 at a CAGR of 6.0% during the period of 2019-2024.

The global market for polymer-free drug-eluting stents should grow from $2.7 billion in 2019 to $3.9 billion by 2024 at a CAGR of 7.9% during the period of 2019-2024.

Report Scope:

This report examines the current and projected market potential of drug-eluting stents. It offers a detailed analysis of the regulatory scenario, competitive environment, pipeline, technological advancement, drivers, restraints and market growth trends. The report also includes market projections through 2024 and the market rank for key market players. The report details the market share of drug-eluting stents based on types of product, application and end user.

By product type, the market is segmented into polymer-based drug-eluting stents and polymer-free drug-eluting stents. By application, the market is segmented into coronary artery disease (CAD) and peripheral artery disease (PAD). By end user, the market is segmented into hospitals, ambulatory surgical centers and specialty centers and clinics.

By geography, the market is segmented into North America, Europe, Asia-Pacific, Latin America and the Middle East and Africa. Detailed analyses of major countries such as the U.S., Canada, Germany, the U.K., France, Spain, Italy, Japan, China and India are covered in regional segments. For market estimates, data is provided for 2018 as the base year, 2019 and forecast through year-end 2024. Estimated values used are based on drug-eluting stent manufacturers' total revenues. Projected and forecasted revenue values are in constant U.S. dollars that have not been adjusted for inflation.

Report Includes:

  • 20 data tables and 18 additional tables
  • An overview of global market for drug-eluting stents within the medical devices industry
  • Estimation of the market size and analyses of market trends, with data from 2018 and 2019, and projections of compound annual growth rates (CAGRs) through 2024
  • Market share analysis of the drug-eluting stents based on product, application, end-use, and region
  • Identification of segments with high growth potential and analysis of future applications of each of the segments
  • Assessment of market dynamics for drug-eluting stents with market drivers and restraints explained, medical device regulations, market background and pipeline analysis of the stents
  • Coverage of prevalence and epidemiology of cardiovascular disease and description of coronary artery disease (CAD) and peripheral artery disease (PAD)
  • Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies
  • Company profiles of the leading market players, including Abbott, B. Braun Melsungen AG, Biotronik SE & Co. KG, Boston Scientific Corp., Medtronic Plc and Cook Medical Inc.

Table of Contents

Chapter 1: Introduction

  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of Report
  • Information Sources
  • Methodology
  • Geographic Breakdown
  • Analyst's Credentials
  • BCC Custom Research
  • Related BCC Research Reports

Chapter 2: Summary and Highlights

  • Market Highlights: Drug-Eluting Stents

Chapter 3: Medical Device Regulations

  • Medical Device Definition and Classification
  • Regulations in the U.S.
  • Code of Federal Regulations
  • Regulations in Europe
  • Regulations in Japan

Chapter 4: Drug-Eluting Stents: Pipeline Analysis

  • Overview

Chapter 5: Drug-Eluting Stents: Market Background

  • Introduction
  • Market Evolution
  • Coating and Polymers
  • Drugs Used in DESs
  • Cardiovascular Diseases (CVDs)
  • Common Types of CVD
  • Symptoms of CVD
  • Risk Factors: CVD
  • Treatment for CVD

Chapter 6: Drug-Eluting Stents: Market Dynamics

  • Market Dynamics
  • Market Drivers
  • Market Restraints

Chapter 7: Impact of COVID-19 Pandemic

  • Introduction
  • Outbreak
  • Symptoms of COVID-19
  • Progression of COVID-19
  • Incubation Period
  • Epidemiology
  • Global Confirmed COVID-19 Cases and Deaths
  • Collaboration Between Organizations and Governments
  • Spread of Disease
  • Current Status and Impact on MedTech
  • Elective and Noncritical Procedures
  • Shift in Manufacturing
  • Regulatory Delays, Clinical Trials and Product Launches
  • Supply Chain Disruptions
  • Medical Tourism

Chapter 8: Market Breakdown, by Product

  • Global Market for Drug-Eluting Stents, by Product
  • Polymer-Based Drug-Eluting Stents
  • Market Size and Forecast
  • Market Analysis
  • Polymer-Free Drug-Eluting Stents
  • Market Size and Forecast
  • Market Analysis

Chapter 9: Market Breakdown, by Application

  • Global Market for Drug-Eluting Stents, by Application
  • Coronary Artery Disease (CAD)
  • Market Size and Forecast
  • Market Analysis
  • Peripheral Artery Disease (PAD)
  • Market Size and Forecast
  • Market Analysis

Chapter 10: Market Breakdown, by End User

  • Global Market for Drug-Eluting Stents, by End User
  • Hospitals
  • Market Size and Forecast
  • Market Analysis
  • Ambulatory Surgical Centers
  • Market Size and Forecast
  • Market Analysis
  • Specialty Centers and Clinics
  • Market Size and Forecast
  • Market Analysis

Chapter 11: Market Breakdown, by Region

  • Global Market for Drug-Eluting Stents, by Region
  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • India
  • Rest of Asia-Pacific
  • Latin America
  • Middle East and Africa

Chapter 12: Competitive Landscape

  • Global Company Share Analysis
  • Mergers and Acquisitions
  • Agreements, Collaborations, Product Launches and Partnerships

Chapter 13: Company Profiles

  • ABBOTT
  • ALVIMEDICA
  • B. BRAUN MELSUNGEN AG
  • BIOSENSORS INTERNATIONAL
  • BIOTRONIK SE & CO. KG
  • BOSTON SCIENTIFIC CORP.
  • COOK MEDICAL INC.
  • LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.
  • MEDTRONIC PLC
  • TERUMO CORP.

Chapter 14: Appendix: List of Acronyms

List of Tables

  • Summary Table A: Global Market for Drug-Eluting Stents, by Product, Through 2024
  • Summary Table C: Global Market for Drug-Eluting Stents, by End User, Through 2024
  • Summary Table B: Global Market for Drug-Eluting Stents, by Application, Through 2024
    • Table 1: Class I and II Exempt Devices
    • Table 2: Selected Clinical Trial Studies: Drug-Eluting Stents
    • Table 3: Selected Coronary Stents
    • Table 4: Drugs Commonly Used in DES
    • Table 5: CVD Risk Factors
    • Table 6: Coronary Angioplasty Procedures, by Country, 2018
    • Table 7: Distribution of COVID-19 Symptoms
    • Table 8: COVID-19: Confirmed Cases and Deaths, by Country, as of Aug. 3, 2020
    • Table 9: Global Market for Drug-Eluting Stents, by Product Segment, Through 2024
    • Table 10: Common Polymers Used in DES
    • Table 11: Coating Methods to Develop Polymer-Free Drug-Eluting Stents
    • Table 12: Global Market for Drug-Eluting Stents, by Application, Through 2024
    • Table 13: Global Market for Drug-Eluting Stents, by End User, Through 2024
    • Table 14: Global Market for Drug-Eluting Stents, by Region, Through 2024
    • Table 15: North American Market for Drug-Eluting Stents, by Country, Through 2024
    • Table 16: Estimated Number of U.S. Stent Procedures, by Type of Procedure, 2014
    • Table 17: European Market for Drug-Eluting Stents, by Country, Through 2024
    • Table 18: Asia-Pacific Market for Drug-Eluting Stents, by Country, Through 2024
    • Table 19: Latin American Market for Drug-Eluting Stents, by Product, Through 2024
    • Table 20: Latin American Market for Drug-Eluting Stents, by Application, Through 2024
    • Table 21: Latin American Market for Drug-Eluting Stents, by End User, Through 2024
    • Table 22: Leading Causes of Death and Percentage Change in Argentina, 2007-2017
    • Table 23: Middle Eastern and African Market for Drug-Eluting Stents, by Product, Through 2024
    • Table 24: Middle Eastern and African Market for Drug-Eluting Stents, by Application, Through 2024
    • Table 25: Middle Eastern and African Market for Drug-Eluting Stent, by End User, Through 2024
    • Table 26: Global Market Shares of Drug-Eluting Stents, by Company, 2019
    • Table 27: Abbott: Drug-Eluting Stents, Product Portfolio
    • Table 28: Alvimedica: Drug-Eluting Stents, Product Portfolio
    • Table 29: B. Braun Melsungen AG: Drug-Eluting Stents, Product Portfolio
    • Table 30: Biosensors International: Drug-Eluting Stents, Product Portfolio
    • Table 31: Biotronik SE & Co. KG: Drug-Eluting Stents, Product Portfolio
    • Table 32: Boston Scientific Corp.: Drug-Eluting Stents, Product Portfolio
    • Table 33: Cook Medical Inc.: Drug-Eluting Stents, Product Portfolio
    • Table 34: Lepu Medical Technology (Beijing) Co., Ltd.: Drug-Eluting Stents, Product Portfolio
    • Table 35: Medtronic Plc: Drug-Eluting Stents, Product Portfolio
    • Table 36: Terumo Corp.: Drug-Eluting Stents, Product Portfolio
    • Table 37: Acronyms Used in the Drug-Eluting Stents Industry

List of Figures

  • Summary Figure C: Global Market for Drug-Eluting Stents, by Application, 2018-2024
  • Summary Figure B: Global Market Shares of Drug-Eluting Stents, by Product, 2019
  • Summary Figure A: Global Market for Drug-Eluting Stents, by Product, 2018-2024
  • Summary Figure D: Global Market Shares of Drug-Eluting Stents, by Application, 2019
  • Summary Figure E: Global Market for Drug-Eluting Stents, by End User, 2018-2024
  • Summary Figure F: Global Market Shares of Drug-Eluting Stents, by End User, 2019
    • Figure 1: Marketing a Medical Device in the U.S.
    • Figure 2: Historical Milestones: Coronary Artery Stenting
    • Figure 3: Global Disease Burden, 2017
    • Figure 4: Adults with Cardiovascular Conditions, by Country, 2019
    • Figure 5: Top 10 Global Causes of Deaths, 2016
    • Figure 6: Global Geriatric Population (Aged 65+ Years), 2014-2022
    • Figure 7: Surgical Operations Performed Globally, 2004 and 2012
    • Figure 8: Global Market Shares of Drug-Eluting Stents, by Product Segment, 2019
    • Figure 9: Global Market for Polymer-Based Drug-Eluting Stents, 2018-2024
    • Figure 10: Global Market for Polymer-Based Drug-Eluting Stents, by Region, 2018-2024
    • Figure 11: Global Market for Polymer-Free Drug-Eluting Stents, 2018-2024
    • Figure 12: Global Market for Polymer-Free Drug-Eluting Stents, by Region, 2018-2024
    • Figure 13: Global Market Shares of Drug-Eluting Stents, by Application, 2019
    • Figure 14: Global Market for Coronary Artery Disease, 2018-2024
    • Figure 15: Global Market for Peripheral Artery Disease, 2018-2024
    • Figure 16: Global Market Shares of Drug-Eluting Stents, by End User, 2019
    • Figure 17: Global Market for Drug-Eluting Stents in Hospital End Use, 2018-2024
    • Figure 18: Global Market for Drug-Eluting Stents in Ambulatory Surgical Center End Use, 2018-2024
    • Figure 19: Global Market for Drug-Eluting Stents in Specialty Center and Clinic End Use, 2018-2024
    • Figure 20: Global Market Shares of Drug-Eluting Stents, by Region, 2019
    • Figure 21: North American Market Shares of Drug-Eluting Stents, by Country, 2019
    • Figure 22: U.S. Market for Drug-Eluting Stents, 2018-2024
    • Figure 23: U.S. Population Aged 65+, Projection and Trends, 2010-2050
    • Figure 24: Distribution of Deaths in the U.S. from CVD, by Disease Sub-Segment, 2016
    • Figure 25: Canadian Market for Drug-Eluting Stents, 2018-2024
    • Figure 26: European Market Shares of Drug-Eluting Stents, by Country, 2019
    • Figure 27: German Market for Drug-Eluting Stents, 2018-2024
    • Figure 28: U.K. Market for Drug-Eluting Stents, 2018-2024
    • Figure 29: French Market for Drug-Eluting Stents, 2018-2024
    • Figure 30: Italian Market for Drug-Eluting Stents, 2018-2024
    • Figure 31: Spanish Market for Drug-Eluting Stents, 2018-2024
    • Figure 32: Rest of European Market for Drug-Eluting Stents, 2018-2024
    • Figure 33: Asia-Pacific Market Shares of Drug-Eluting Stents, by Country, 2019
    • Figure 34: Japanese Market for Drug-Eluting Stents, 2018-2024
    • Figure 35: Chinese Market for Drug-Eluting Stents, 2018-2024
    • Figure 36: Shares of Major Causes of Death in Rural China, 2016
    • Figure 37: Shares of Major Causes of Death in Urban China, 2016
    • Figure 38: Indian Market for Drug-Eluting Stents, 2018-2024
    • Figure 39: Rest of Asia-Pacific Market for Drug-Eluting Stents, 2018-2024
    • Figure 40: Latin American Market for Drug-Eluting Stents, 2018-2024
    • Figure 41: Latin American Market Shares of Drug-Eluting Stents, by Product, 2019
    • Figure 42: Middle Eastern and African Market for Drug-Eluting Stents, 2018-2024
    • Figure 43: Middle Eastern and African Market Shares of Drug-Eluting Stents, by Product, 2019
    • Figure 44: Abbott: Annual Revenue, 2017-2019
    • Figure 45: Abbott: Revenue Share, by Country, 2019
    • Figure 46: Abbott: Revenue Share, by Product Category, 2019
    • Figure 47: B. Braun Melsungen AG: Annual Revenue, 2017-2019
    • Figure 48: B. Braun Melsungen AG: Revenue Share, by Business Division, 2019
    • Figure 49: B. Braun Melsungen AG: Revenue Share, by Country/Region, 2019
    • Figure 50: Boston Scientific Corp.: Annual Revenue, 2017-2019
    • Figure 51: Boston Scientific Corp.: Revenue Share, by Product Category, 2019
    • Figure 52: Boston Scientific Corp.: R&D Expenditures, 2017-2019
    • Figure 53: Lepu Medical Technology (Beijing) Co., Ltd.: Annual Revenue, 2017-2019
    • Figure 54: Medtronic Plc: Annual Revenue, 2017-2019
    • Figure 55: Medtronic Plc: Revenue Share, by Country/Region, 2019
    • Figure 56: Medtronic Plc: Revenue Share, by Product Category, 2019
    • Figure 57: Terumo Corp.: Annual Revenue, 2017-2019
    • Figure 58: Terumo Corp.: Revenue Share, by Product Category, 2019